Literature DB >> 13120279

Serum mucoproteins in patients with rheumatic fever.

V C KELLEY, F H ADAMS, R A GOOD.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; BLOOD PROTEINS; CORTISONE/therapeutic use; RHEUMATIC FEVER/blood in

Mesh:

Substances:

Year:  1953        PMID: 13120279

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  8 in total

1.  CLINICAL USES OF SEROMUCOID ESTIMATION.

Authors:  J W KEYSER
Journal:  Postgrad Med J       Date:  1964-04       Impact factor: 2.401

2.  Plasma seromucoids in acute rheumatic fever: a preliminary study.

Authors:  R BARCELO; G GILBERT; A MARCHAND; P DAVID
Journal:  Can Med Assoc J       Date:  1962-10-27       Impact factor: 8.262

3.  Content and composition of the mucoprotein fraction of human serum (seromucoid) in disease with special reference to hematologic disorders.

Authors:  E MOSCHIDES; M STEFANINI; S I MAGALINI; S A KISTNER
Journal:  J Clin Invest       Date:  1958-01       Impact factor: 14.808

4.  Diagnosis of rheumatic fever and like conditions; evaluation of certain of the acute phase reactants in a single specimen of blood.

Authors:  F H ADAMS
Journal:  Calif Med       Date:  1956-08

5.  The rebound phenomenon in acute rheumatic fever.

Authors:  K S HOLT
Journal:  Arch Dis Child       Date:  1956-12       Impact factor: 3.791

6.  The hexosamine content of the serum globulins in normal and pathological sera.

Authors:  A J BOLLET
Journal:  J Clin Invest       Date:  1957-01       Impact factor: 14.808

7.  Effects of oxyphenbutazone (tandearil) on plasma seromucoids. II. In postoperative inflammation.

Authors:  R BARCELO; C LEBLANC; P RIOPEL; L P LEGRESLEY
Journal:  Can Med Assoc J       Date:  1963-03-23       Impact factor: 8.262

8.  Effects of oxyphenbutazone (Tandearil) on plasma seromucoids. I. In experimental inflammation.

Authors:  R BARCELO; P RIOPEL; L P LEGRESLEY
Journal:  Can Med Assoc J       Date:  1963-03-16       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.